Resultado de búsqueda
Hace 5 horas · Readers say the system is not broken and praise the jurors who did their job; criticize Tarrant County Sheriff Bill Waybourn; and disagree with the Texas Medical Association on gender ideology ...
Hace 11 horas · Saish Gawthankar, visually impaired student who recently scored 80% in his SSC Board Examination without the assistance of a scribe and used a computer, was a student of Santa Cruz High School and the National Association for the Blind (NAB). A barrier-free environment was created to facilitate his and other visually impaired students’ education.
4 de jun. de 2024 · Greyhound racing: free full fields for bulli form guide (race 10) | full fields race 10 for monday, 03rd june 2024.
Hace 11 horas · 57% of patients treated with IMFINZI were alive at three years in ADRIATIC Phase III trial. WILMINGTON, DE, USA I June 02, 2024 I Positive results from the ADRIATIC Phase III trial showed AstraZeneca’s IMFINZI ® (durvalumab) demonstrated statistically significant and clinically meaningful improvements in the dual primary endpoints of overall survival (OS) and progression-free survival (PFS ...
Hace 11 horas · Joy Ojo, a celebrated Nigerian boxer with a collection of four gold medals, recently shared her elation in a viral interview conducted in her home country. She spoke of her ambition to join the ranks of Olympic athletes and her readiness to pursue international opportunities to advance her prowess ...
Hace 11 horas · Except it wasn’t fine! Tony had been right to call him out on his BS attitude. In his own defence, Jethro badly underestimated how much blind ambition Leon possessed, plus how far Vance and SECNAV were willing to go so they could curry favour with Mossad. It was nothing short of treason he could see that… now that it was much too late.
Hace 11 horas · AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients. The Company’s focus is on some of the most challenging cancers.
